Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

STIM - Neuronetics, Inc.

IEX Last Trade
1.37
0.010   0.730%

Share volume: 4,364
Last Updated: Thu 26 Dec 2024 08:26:02 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%
$1.36
0.01
0.74%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
13%
Profitability 8%
Dept financing 24%
Liquidity 71%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
9.77%
1 Month
53.04%
3 Months
87.18%
6 Months
-15.61%
1 Year
-46.52%
2 Year
-75.54%
Key data
Stock price
$1.37
P/E Ratio 
-0.82
DAY RANGE
$1.31 - $1.38
EPS 
-$1.11
52 WEEK RANGE
$0.69 - $5.07
52 WEEK CHANGE
-$48.23
MARKET CAP 
26.754 M
YIELD 
N/A
SHARES OUTSTANDING 
30.295 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
1.55
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$259,194
AVERAGE 30 VOLUME 
$240,318
Company detail
CEO: Keith J. Sullivan
Region: US
Website: neurostar.com
Employees: 180
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Neuronetics, Inc. offers non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.

Recent news